Skip to Main Content

In the latest bid to pull back the curtain on pharmacy benefit managers, the Louisiana Attorney General filed a lawsuit accusing OptumRx of inflating the price of prescription drugs that cost the state Medicaid program billions of dollars.

The lawsuit alleges that OptumRx, which is one of the largest pharmacy benefit managers, and its corporate parent, UnitedHealth Group, used a series of opaque tactics that ultimately caused the state to be overcharged for medicines. The companies also refused to provide requested documents and data, according to the lawsuit, which was filed in a Louisiana state court.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Create a display name to comment

This name will appear with your comment